PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
31369645-3	2019	Here we examined sitravatinib (MGCD516), a spectrum-selective TKI able to block MET, TAM (TYRO3, AXL, MerTK) and multiple receptor families (including PDGFRs, VEGFRs, and Ephs).	sitravatinib	17-29	Myeloproliferative syndrome, transient (transient abnormal myelopoiesis)	Homo sapiens	85-88	
31369645-3	2019	Here we examined sitravatinib (MGCD516), a spectrum-selective TKI able to block MET, TAM (TYRO3, AXL, MerTK) and multiple receptor families (including PDGFRs, VEGFRs, and Ephs).	sitravatinib	31-38	Myeloproliferative syndrome, transient (transient abnormal myelopoiesis)	Homo sapiens	85-88